Restless Leg Syndrome Due to Uraemia study: Dipyridamole
Official title A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With Dipyridamole
ClinicalTrials.gov ID: NCT07199504
What this study is testing
What is Dipyridamole 50mg tid?
Dipyridamole 50mg tid is an investigational medicine, taken by mouth once daily, being studied as a potential treatment for restless leg syndrome due to uraemia.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study checks if dipyridamole can reduce restless legs symptoms and improve sleep and mood. It also looks for any side effects.
- Who it's for
- People with kidney failure who have restless legs syndrome.
- What's involved
- Participants take dipyridamole pills three times a day. They will have tests before and after treatment to check for changes.
- Time commitment
- The study lasts 12 weeks with regular check-ins to monitor safety.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- (1) Maintenance hemodialysis for ≥3 months;(2) Age between 18-75 years;(3) Diagnosed with Restless Legs Syndrome (RLS) according to IRLSSG standards...
You likely can't join if
- (1). Patients with other cerebrovascular, muscular, and movement system diseases affecting the assessment of RLS;(2).
The study team makes the final eligibility decision.
Where it is enrolling
- Chongqing, Chongqing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Chongqing, Chongqing Municipality, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.